Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study

Herein we have selected seventeen anti-lung cancer drugs to screen against Mpro, PLpro and spike glycoproteins of SARS-CoV-2to ascertain the potential therapeutic agent against COVID-19. ADMET profiling were employed to evaluate their pharmacokinetic properties. Molecular docking studies revealed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Reza, Rahimasoom, Dutta, Tanmoy, Baildya, Nabajyoti, Ghosh, Narendra Nath, Khan, Abdul Ashik, Das, Rajesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174081/
https://www.ncbi.nlm.nih.gov/pubmed/35690231
http://dx.doi.org/10.1016/j.micpath.2022.105615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174081/
https://www.ncbi.nlm.nih.gov/pubmed/35690231
http://dx.doi.org/10.1016/j.micpath.2022.105615

Ejemplares similares